Next Article in Journal
Synthesis and Structural Characterization of (E)-4-[(2-Hydroxy-3-methoxybenzylidene)amino]butanoic Acid and Its Novel Cu(II) Complex
Next Article in Special Issue
N-(6-Chloro-3-nitropyridin-2-yl)-5-(1-methyl-1H-pyrazol-4-yl)isoquinolin-3-amine
Previous Article in Journal
N-(2-(1H-Indol-3-yl)ethyl)-2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide
Previous Article in Special Issue
Methyl (2E)-3-[3-Benzyl-2-(3-methoxy-3-oxoprop-1-yn-1-yl)-2-(1-naphthyl)imidazolidin-1-yl]acrylate
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

(S)-1-(Ethoxycarbonyl)ethyl(2R,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate

EaStCHEM School of Chemistry, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, UK
*
Author to whom correspondence should be addressed.
Molbank 2021, 2021(1), M1178; https://doi.org/10.3390/M1178
Submission received: 23 December 2020 / Revised: 29 December 2020 / Accepted: 30 December 2020 / Published: 2 January 2021
(This article belongs to the Collection Heterocycle Reactions)

Abstract

:
The title compound was obtained in low yield in the condensation of ethyl pyruvate and lactic acid. Its structure is determined by NMR methods and x-ray diffraction and the mechanism for formation of this 1:2 adduct from the initial 1:1 adduct is considered.

1. Introduction

In the course of recent studies towards the synthesis of the cytotoxic natural product citrinoviric acid [1] (Figure 1) we identified the simple dioxolanone ester 1 as a key intermediate, planning to make use of our previously reported deprotonation and alkylation at C-5 [2] to introduce the required side-chain. We envisaged formation of the compound by simple condensation between (S)-lactic acid and ethyl pyruvate using the method reported by Seebach [3]. When our work was carried out, compound 1 was not known, but it was subsequently described together with the corresponding methyl ester in a patent [4], although these were only characterised by boiling point with no spectroscopic data. We describe here the synthesis and full characterisation of 1, but also the formation and identification by spectroscopic and X-ray diffraction methods of an unexpected 2:1 heterocyclic adduct 2.

2. Results and Discussion

Condensation of ethyl pyruvate and a slight excess of (S)-lactic acid with acid catalysis in pentane under Dean–Stark conditions of azeotropic water removal [3] gave complete reaction after 12 h. Washing with water to remove the acids, evaporation of the pentane and chromatographic separation of the residue then afforded three compounds (Scheme 1). The main components were the desired dioxolanone 1 (23%) and its diastereomer 1′ (7%). While the major product 1 was obtained in pure form, the minor isomer 1′ was always contaminated by varying amounts of 1 so the NMR data of 1′ are taken from the mixture. The stereochemistry at the newly formed C-2 centre is assumed to be (R) for the major isomer 1 since this places the larger ester group trans to the 5-methyl and it is also consistent with the stereochemistry in product 2 as determined by X-ray diffraction (see below). The 1H-NMR spectrum showed an interesting pattern for the OCH2 protons which were non-equivalent and coupled to each other, giving a pattern which could be analysed with the aid of a simulation as an AB pattern of quartets (Supplementary Material S2).
The third product 2 gave similar NMR signals to 1 and 1′ but with an additional lactic acid-derived –OCH(Me)C=O– group present, and this was confirmed by the HRMS. Interestingly the OCH2 protons of the ester again formed an AB pattern of quartets with identical coupling constants to those observed for 1. We initially suspected that it might have the eight-membered ring structure 2′ (Figure 2) which could be formed by direct condensation of the two reacting components, but this was not consistent with the results of 2D NMR experiments (see Supplementary Material Figures S8 and S9). In particular, HMBC showed that one CHMe proton was interacting with both the ethyl ester carbonyl and one other carbonyl, with this second carbonyl rather than the ethyl ester interacting with the quaternary CMe methyl protons. The isomeric dioxolanone stucture 2, with the extra lactic acid unit effectively inserted into the ester group of 1, was however consistent with all the NMR data and the chemical shifts could be fully assigned as shown in Figure 2.
The structure of 2 was confirmed beyond doubt by a single crystal X-ray diffraction study (Figure 3). In this the dioxolanone ring adopts an approximate envelope conformation with the plane defined by O1-C5-O4 (the flap) at an angle of 22° to the plane of O1-C2-C3-O4. The large ester substituent at C-2 (crystallographic C(5)) then adopts an axial configuration with the methyl equatorial while at C-5 (crystallographic C(3)) the methyl and hydrogen substituents are symmetrically placed above and below the ring.
(a) (b)
We believe this unexpected product results from reaction of the primary product 1 with a further equivalent of lactic acid. It is tempting to speculate that this may involve an acid-catalysed intramolecular transfer of the ethoxy group as shown in Scheme 2, although we are unable to exclude the possibility that there is simple transesterification between 1 and lactic acid leading to the dioxolanonecarboxylic acid and ethyl lactate which then undergo condensation.

3. Experimental

Melting points were recorded on a Reichert hot-stage microscope (Reichert, Vienna, Austria) and are uncorrected. IR spectra were recorded on a Perkin-Elmer 1420 instrument (Perkin-Elmer, Waltham, MA, USA). NMR spectra were obtained for protons at 500 MHz and for carbon at 125 MHz using a Bruker AVIII 500 instrument (Bruker, Billerica, MA, USA). Spectra were run at 25 °C on solutions in CDCl3 with internal Me4Si as the reference. Chemical shifts are reported in ppm to high frequency of the reference and coupling constants J are in Hz. Experimental and simulated NMR spectra were processed using i-NMR Reader version 6.1.7 (see www.inmr.net).
Procedure for synthesis of 1, 1′ and 2: A solution of (S)-lactic acid (90%, 5.0 g, 50 mmol), ethyl pyruvate (5.0 g, 43 mmol), p-toluenesulfonic acid monohydrate (0.05 g, 0.25 mmol) and conc. sulfuric acid (0.25 cm3) in pentane (50 cm3) was heated to reflux with azeotropic removal of water under Dean–Stark conditions for 12 h. The reaction mixture was cooled and washed with water (3 × 20 cm3). The organic layer was separated, dried over anhydrous MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column chromatography (SiO2, 2:1 hexane: diethyl ether as eluent) to give:
Ethyl (2R,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate 1: The title compound was isolated as a clear colourless liquid (1.86 g, 23%); [ α ] D 21 +17.9 (c 1.0 in CH2Cl2); υmax(cm−1) 2990 (C–H), 1817 (C=O), 1753 (C=O), 1304, 1250, 1146 and 941; 1H-NMR (500 MHz, CDCl3) δH: 4.65 (1H, q, J 6.8, 5-CH), 4.280 and 4.264 (2H, AB pattern of q, JAB 11.0, J 7.0, OCH2), 1.79 (3H, s, 2-CH3), 1.50 (3H, d, J 6.8, 5-CH3) and 1.33 (3H, t, J 7.0, CH2CH3); 13C {1H} NMR (125 MHz, CDCl3) δC: 173.0 (C-4), 167.0 (CO2Et), 104.1 (C-2), 71.2 (5-CH), 62.6 (OCH2), 21.9 (2-CH3), 17.1 (5-CH3) and 13.9 (CH2CH3); HRMS (ESI+) C8H12NaO5 [M + Na]+ found 211.0570, requires 211.0582.
Ethyl (2S,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate 1′: The title compound was isolated as a clear colourless liquid (566 mg, 7%) slightly contaminated by 1; 1H-NMR (500 MHz, CDCl3) δH: 4.59 (1H, q, J 6.8, 5-CH), 4.294 and 4.278 (2H, AB pattern of q, JAB 11.0, J 7.0, OCH2), 1.76 (3H, s, 2-CH3), 1.53 (3H, d, J 6.8, 5-CH3) and 1.34 (3H, t, J 7.1, CH2CH3); 13C {1H} NMR (75 MHz, CDCl3) δC: 172.5 (C-4), 167.3 (CO2Et), 104.7 (C-2), 71.0 (5-CH), 62.6 (OCH2), 22.3 (2-CH3), 17.2 (5-CH3) and 13.7 (CH2CH3).
(S)-1-(Ethoxycarbonyl)ethyl(2R,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate 2: The title compound was isolated as a clear colourless liquid (224 mg, 4%) which gradually crystallised with time to a colourless low melting solid, mp 34–36 °C; υmax(cm−1) 2988 (C–H), 1813 (C=O), 1751 (C=O), 1449, 1248, 1132 and 941; 1H-NMR (500 MHz, CDCl3) δH: 5.15 (1H, q, J 7.0, 2’-CH), 4.66 (1H, q, J 7.0, 5-CH), 4.223 and 4.207 (2H, AB pattern of q, JAB 11.0, J 7.0, OCH2), 1.84 (3H, s, 2-CH3), 1.57 (3H, d, J 7.0, 2’-CH3), 1.52 (3H, d, J 7.0, 5-CH3) and 1.28 (3H, t, J 7.0, CH2CH3); 13C-NMR (125 MHz, CDCl3) δC: 172.8 (C-4), 169.4 (C-1’), 166.5 (2-CO), 103.9 (C-2), 71.3 (C-5), 70.3 (C-2’), 61.8 (CH2CH3), 21.9 (2-Me), 16.9 (5-Me), 16.7 (2’-Me) and 14.0 (CH2CH3); HRMS (ESI+) C11H16NaO7 [M + Na]+ found 283.0786, requires 283.0794.
X-ray structure determination: Crystal data for C11H16O7, M = 260.24 g mol–1, colourless prism, crystal dimensions 0.12 × 0.03 × 0.02 mm, orthorhombic, space group P212121 (No. 19), a = 4.8832(7), b = 7.5868(12), c = 35.478(6) Å, V = 1314.4(4) Å3, Z = 4, Dcalc = 1.315 g cm–3, T = 93 K, R1 = 0.0360, Rw2 = 0.0899 for 2149 reflections with I > 2σ(I), and 163 variables. Data were collected using graphite monochromated Mo Kα radiation λ = 0.71075 Å and have been deposited at the Cambridge Crystallographic Data Centre as CCDC 1989784. The data can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/getstructures. The structure was solved by direct methods and refined by full-matrix least-squares against F2 (SHELXL Version 2014/7 [5]). Hydrogen atoms were assigned riding isotropic displacement parameters and constrained to idealised geometries.

Supplementary Materials

The following are available online, Figure S1: 1H-NMR spectrum of 1; Figure S2: Detail of OCH2 signal in 1H-NMR spectrum of 1; Figure S3: 13C-NMR spectrum of 1; Figure S4: 1H-NMR spectrum of ca. 3:1 mixture of 1′ and 1; Figure S5: 13C-NMR spectrum of ca. 5:4 mixture of 1′ and 1; Figure S6: 1H-NMR spectrum of 2; Figure S7: 13C-NMR spectrum of 2; Figure S9: COSY 2D H–H correlation spectrum of 2; Figure S9: HMBC 2D C–H correlation spectrum of 2.

Author Contributions

O.E.H. prepared the compound; A.M.Z.S. collected the x-ray data and solved the structure; R.A.A. designed the experiments, analysed the data, and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding

Data Availability Statement

The X-ray data is at CCDC as stated in the paper and all NMR data is in the Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Hu, X.; Gong, M.-W.; Zhang, W.-W.; Zheng, Q.-H.; Liu, Q.-Y.; Chen, L.; Zhang, Q.-Q. Novel cytotoxic metabolites from the marine-derived fungus Trichoderma citrinoviride. Heterocycles 2014, 89, 189–196. [Google Scholar] [CrossRef]
  2. Aitken, R.A.; Thomas, A.W. Behaviour of dioxolanones as chiral acyl anion equivalents. Synlett 1998, 102–104. [Google Scholar] [CrossRef]
  3. Seebach, D.; Naef, R.; Calderari, G. α-Alkylation of α-heterosubstituted carboxylic acids without racemisation: EPC synthesis of tertiary alcohols and thiols. Tetrahedron 1984, 40, 1313–1324. [Google Scholar] [CrossRef]
  4. Fang, G. Method for Preparing 2,5-dimethyl-4-hydroxy-3(2H)-furanone. Chinese Patent 106588837 A, 26 April 2017. [Google Scholar]
  5. Sheldrick, G.M. A short history of SHELXL. Acta Crystallogr. Sect. A 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Citrinoviric acid and the target synthetic intermediate.
Figure 1. Citrinoviric acid and the target synthetic intermediate.
Molbank 2021 m1178 g001
Scheme 1. Synthetic route to 1, 1′ and 2.
Scheme 1. Synthetic route to 1, 1′ and 2.
Molbank 2021 m1178 sch001
Figure 2. Structures considered for the 2:1 adduct and NMR data.
Figure 2. Structures considered for the 2:1 adduct and NMR data.
Molbank 2021 m1178 g002
Figure 3. The molecular structure of 2 (a) with numbering scheme and anisotropic displacement ellipsoids drawn at the 50% probability level and (b) redrawn to show ring conformation.
Figure 3. The molecular structure of 2 (a) with numbering scheme and anisotropic displacement ellipsoids drawn at the 50% probability level and (b) redrawn to show ring conformation.
Molbank 2021 m1178 g003
Scheme 2. Possible route for the formation of 2 from 1 with intramolecular ethoxide transfer.
Scheme 2. Possible route for the formation of 2 from 1 with intramolecular ethoxide transfer.
Molbank 2021 m1178 sch002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Aitken, R.A.; Haslett, O.E.; Slawin, A.M.Z. (S)-1-(Ethoxycarbonyl)ethyl(2R,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate. Molbank 2021, 2021, M1178. https://doi.org/10.3390/M1178

AMA Style

Aitken RA, Haslett OE, Slawin AMZ. (S)-1-(Ethoxycarbonyl)ethyl(2R,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate. Molbank. 2021; 2021(1):M1178. https://doi.org/10.3390/M1178

Chicago/Turabian Style

Aitken, R. Alan, Oliver E. Haslett, and Alexandra M. Z. Slawin. 2021. "(S)-1-(Ethoxycarbonyl)ethyl(2R,5S)-2,5-dimethyl-1,3-dioxolan-4-one-2-carboxylate" Molbank 2021, no. 1: M1178. https://doi.org/10.3390/M1178

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop